Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,948
Active & Responsive
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine
for
Preventive Treatment of Migraine
Location: Dallas TX, Austin TX, Oklahoma City OK, Memphis TN,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07729462
Phase 3, Recruiting
Active & Responsive
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
for
Overweight, Obesity
Location: Dallas TX, Austin TX, Houston TX, San Antonio TX,
DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.
for
Obstructive Sleep Apnea (OSA)
Location: Dallas TX, San Antonio TX, Memphis TN, Cincinnati OH,
Sponsor: Incannex Healthcare Ltd
Sex: All
Age: 18 - 65
Code: NCT07635563
Phase 2, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
for
Menstrual Migraine
Location: Dallas TX, Austin TX, Springfield MO, Weldon Spring MO,
Sponsor: Pfizer
Sex: Female
Age: 18 - 45
Code: NCT06641466
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
for
Heart Failure With Preserved Ejection Fraction,
Location: Dallas TX, Duncanville TX, Plano TX, McKinney TX,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07037459
Phase 3, Recruiting
Active & Responsive
Prospective US Radiofrequency SUI Trial
for
Urinary Incontinence, Stress
Location: Irving TX, Shreveport LA, Houston TX, San Antonio TX,
Successful Transitions and Reintegration Tools for Veterans (START-VETS)
for
Substance Use Disorder, Mental Illness, Recently Incarcerated
Location: Dallas TX
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT04366531
Recruiting
Active & Responsive
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)
for
Alcohol Use Disorder
Location: Dallas TX, Houston TX, Hines IL, Madison WI,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18 - 70+
Code: NCT07218354
Phase 3, Recruiting
Active & Responsive
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
for
Opioid Use Disorder
Location: Dallas TX, Dayton OH, Milwaukee WI, Phoenix AZ,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT04375033
Recruiting
Active & Responsive
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)
for
Angiokeratomas
Location: Southlake TX, Dawsonville GA
Sponsor: Palvella Therapeutics, Inc.
Sex: All
Age: 6+
Code: NCT07552077
Phase 2, Recruiting
Active & Responsive
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
for
Psoriatic Arthritis, Axial Spondyloarthritis
Location: Colleyville TX, Mesquite TX, Plano TX, Baytown TX,
Sponsor: UCB Biopharma SRL
Sex: All
Age: 18+
Code: NCT07290036
Phase 1, Recruiting
Active & Responsive
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
for
Center Involved Diabetic Macular Edema, Diabetic Macular Edema
Location: Southlake TX, Bellaire TX, La Crosse WI,
Sponsor: Ocugen
Sex: All
Age: 18+
Code: NCT05802329
Phase 1, Recruiting
Active & Responsive
OssDsign® Spine Registry Study ("Propel")
for
Degenerative Disc Disease, Spinal Stenosis
Location: Addison TX, Southfield MI, Miami FL, State College PA,
Sponsor: OssDsign
Sex: All
Age: 21+
Code: NCT05329129
Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis